Adherence to heart failure management medications following cardiac resynchronization therapy

References

• McMurray JJ, Adamopoulos S, Anker SD. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–869.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239.
   PubMed Web of Science ®Google Scholar
• Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF study group. JAMA. 2000;283(10):1295–1302.
   PubMed Web of Science ®Google Scholar
• Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106(17):2194–2199.
   PubMed Web of Science ®Google Scholar
• Albouaini K, Egred M, Rao A, et al. Cardiac resynchronisation therapy: evidence based benefits and patient selection. Eur J Intern Med. 2008;19(3):165–172.
   PubMed Web of Science ®Google Scholar
• Khand A, Gemmel I, Clark AL, et al. Is the prognosis of heart failure improving? J Am Coll Cardiol. 2000;36(7):2284–2286.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845–1853.
   PubMed Web of Science ®Google Scholar
• Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation. 2004;109(3):300–307.
   PubMed Web of Science ®Google Scholar
• Calvert MJ, Freemantle N, Yao G, et al. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J. 2005;26(24):2681–2688.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–1549.
   PubMed Web of Science ®Google Scholar
• Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol. 2005;46(12):2311–2321.
   PubMed Web of Science ®Google Scholar
• Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–1843.
   PubMed Web of Science ®Google Scholar
• Truven Health Analytics [Internet]. The Truven Health MarketScan Databases for Health Services Researchers [cited 2019 Sep 26]. Available from: https://truvenhealth.com/portals/0/assets/2017_MarketScan_Databases_Health_Services_Researchers.pdf.
   Google Scholar
• Page RL, O’Bryant CL, Cheng D, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(6):e32–e69.
   PubMed Web of Science ®Google Scholar
• Auricchio A, Lumens J, Prinzen FW. Does cardiac resynchronization therapy benefit patients with right bundle branch block. Circ Arrhythm Electrophysiol.. 2014;7(3):532–542.
   PubMed Web of Science ®Google Scholar
• Pham D, Grodin JL. Dilemmas in the dosing of heart failure drugs: titrating diuretics in chronic heart failure. Card Fail Rev. 2017;3(2):108–112.
   PubMedGoogle Scholar
• Krueger K, Griese-Mammen N, Schubert I, et al. In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. Heart Fail Rev. 2018;23(1):63–71.
   PubMed Web of Science ®Google Scholar
• Ho PM, Lambert-Kerzner A, Carey EP, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial intervention to improve cardiac drug adherence intervention to improve cardiac drug adherence. JAMA Intern Med. 2014;174(2):186–193.
   PubMed Web of Science ®Google Scholar
• NCfCDPaHP (NCCDPHP) [Internet]. Calculating proportion of days covered (PDC) for antihypertensive and antidiabetic medications: an evaluation guide for grantees; 2015 [cited 2019 Jul 29]. Available from: https://www.cdc.gov/dhdsp/docs/med-adherence-evaluation-tool.pdf.
   Google Scholar
• Fairman KA, Matheral B. Evaluating medication adherence: which measure is right for your program? JMCP. 2000;6(6):499–506.
   Google Scholar
• Abraham WT. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors. Europace. 2013;15(suppl 1):i40–i46.
   PubMed Web of Science ®Google Scholar
• Witt CT, Kronborg MB, Nohr EA, et al. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival. Eur Heart J Cardiovasc Pharmacother. 2015;1(3):182–188.
   PubMed Web of Science ®Google Scholar
• Davidson E, Lam S, Sokn E. Predictors of medication nonadherence from outpatient pharmacy data within a large, Academic Health System. J Pharm Prac. 2019;32(2):175–178.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137–e161.
   PubMed Web of Science ®Google Scholar